Comparison of 1% and 3% Polidocanol Foam in Ultrasound Guided Sclerotherapy of the Great Saphenous Vein: A Randomised, Double-Blind Trial with 2 Year-Follow-up. “The 3/1 Study”  by Hamel-Desnos, C. et al.
Design and methods: Patients who had undergone surgical revascu-
larization between February 2001 and February 2005 and who were aged
65 years, were identified from a prospective database and contacted via a
postal questionnaire.
Results: Of 139 patients identified 19 had died. Questionnaires were
returned by 80/120 patients (66.7%). Of these 8, 36 and 36 patients had
undergone aortic, groin or infra-inguinal procedures respectively. Pre-oper-
atively, 59 were employed, 17 unemployed and 4 retired. Post-operatively,
51 returned to work, 16 were unemployed, and 13 retired. Those who
retired post-operatively were significantly older (p  0.05) than the remain-
der. After a median hospital stay of 15 (iqr 4–45) days those returning to
work did so after a further 26 (iqr 7–112) days, although this was delayed
following aortic procedures (p  0.05) and in patients with non-intermedi-
ate occupations (p  0.05).
Conclusions: Two thirds of potentially employable patients with clau-
dication return to work following surgery including all those undergoing
lower limb revascularization who were employed pre-operatively. This is
influenced by age, the type of procedure and pre-operative occupation. This
data can be used to predict return to work in patients requiring surgery for
intermittent claudication.
Long-term Results of Surgical Repair of Popliteal Artery Aneurysm
Davies R.S.M., Wall M., Rai S., Simms M.H., Vohra R.K., Bradbury A.W.,
Adam D.J. Eur J Vasc Endovasc Surg 2007;34:714-8.
Objective: To determine the long-term outcome of surgical repair of
popliteal artery aneurysms (PAA).
Methods: A retrospective review of consecutive patients who under-
went surgical PAA repair in two vascular surgery units between 1988 and
2006 was performed. Primary and secondary graft patency, limb salvage and
patient survival rates were determined using Kaplan-Meier methods.
Results: 48 patients underwent repair of 63 PAAs (ligation and by-
pass45, interposition grafting18). The 5-year primary graft patency,
secondary graft patency, limb salvage and patient survival rates were 75%,
95%, 98% and 81%, respectively. The 10-year primary graft patency rates
were significantly lower for emergency cases (59%) compared with elective
cases (66%) (p  0.0023). Thirteen patients (16 PAAs) required a total of
20 late re-interventions. Duplex ultrasound was available in 33 of 45 PAAs
treated by ligation and bypass. Five(15%) PAAs demonstrated perfusion of
the aneurysm sac at median(range) follow up of 75(1–246) months after
primary repair and two of these required emergency re-operation.
Conclusions: These data demonstrate that surgical PAA repair is
associated with excellent long-term durability and provide an important
benchmark with which to compare results of endovascular PAA repair.
Patients treated using the ligation and bypass technique should be enrolled
in an aneurysm sac surveillance program.
Comparison of 1% and 3% Polidocanol Foam in Ultrasound Guided
Sclerotherapy of the Great Saphenous Vein: A Randomised, Double-
Blind Trial with 2 Year-Follow-up. “The 3/1 Study”
Hamel-Desnos C., Ouvry P., Benigni J.-P., Boitelle G., Schadeck M.,
Desnos P., Allaert F.-A. Eur J Vasc Endovasc Surg 2007;34:723-9.
Objectives: To compare 1% and 3% POL foam in treating the great
saphenous vein (GSV) by ultrasound guided sclerotherapy.
Design: Multicentre, prospective, randomised, double-blind trial with
2 year-follow-up.
Patients and methods: 148 patients with GSV reflux (saphenous
trunk diameter 4–8 mm) were randomised to undergo ultrasound guided
foam sclerotherapy using either 1% or 3% POL foam in a single session. Foam
production was standardised using a sterile disposable syringe kit including
sterile air and the Turbofoam® machine. Duplex ultrasonography was used
to assess the outcome at 3 weeks, 6 months, 1 year, 18 months and 2 years.
The main criterion of success was the disappearance of the venous reflux.
The length of occlusion of the vein (only measured at 3 week-echography
assessment) was a secondary criterion. Side effects were assessed.
Results: 74 patients were included in each group. The mean volume of
foam injected was 4.4 ml for the 3% group and 4.6 ml for the 1% group.
After 3 weeks, reflux was abolished in 96% (71 patients) of the 3% group and
88% (68 patients) of the 1% group (NS). The mean occlusion length of the
vein was 38 cm for the 3% group and 34 for the 1% group (NS). After
2-years, reflux was absent in 69% of the 3% group and 68% of the 1% group
(NS). 14 patients were lost to follow-up at 2 years.
Conclusion: This study demonstrates equivalent efficacy for 1% POL
and 3% POL foam in sclerotherapy of the GSV where the trunk is less than
8 mm in diameter. These data obtained two years of follow-up confirm our
previously reported 6 month-follow-up data published in 2005.
Readers can access EJVES articles at http://intl.elsevierhealth.com/journals/ejvs/default.cfm
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